Gemtuzumab ozogamicin monotherapy prior to stem cell infusion induces sustained remission in a relapsed acute myeloid leukemia patient after allogeneic stem cell transplantation: A case report

RATIONALE: Patients with relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) have poor prognosis. Many patients are not eligible for 2nd HSCT due to organ dysfunction or other complications that prevent them from tolerating conditioning chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumiyoshi, Ritsu, Tashiro, Haruko, Saito, Sumiko, Matsuo, Takuji, Yamamoto, Tadashi, Matsumoto, Kensuke, Ooi, Jun, Shirafuji, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458206/
https://www.ncbi.nlm.nih.gov/pubmed/32871966
http://dx.doi.org/10.1097/MD.0000000000022064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458206/
https://www.ncbi.nlm.nih.gov/pubmed/32871966
http://dx.doi.org/10.1097/MD.0000000000022064

Ejemplares similares